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In 1994, two meta-analyses of the relationships
between childhood lead exposure and IQ
appeared (Pocock et al. 1994; Schwartz 1994).
Both dealt with a problem that arises in the
interpretation of prospective studies in which
the child’s blood lead concentration peaks at
about 2 years of age, but IQ can only be meas-
ured stably (with higher test–retest correlation)
in children ≥ 4 years of age (Sternberg et al.
2001). Both meta-analyses focused on the
strength of association between IQ at school
age and either blood lead concentration meas-
ured at 2 years of age or derived measures of
lead exposure, such as average blood lead
up to 3 years of age, which was found to be
correlated strongly with 2-year blood lead
concentration.
One meta-analysis (Pocock et al. 1994)
included cross-sectional studies in a separate
analysis; those studies also showed an inverse
association of blood lead concentration with
IQ at ≥ 6 years of age. The other meta-analysis
(Schwartz 1994) included cross-sectional
studies in the overall model, but additional
analysis of cross-sectional studies showed
findings similar to those in the prospective
studies. Both meta-analyses concluded that
the prospective design was more reliable in
studying blood lead–IQ associations, because
reverse causality, in which impaired children
ingest more leaded paint or dust, was less
likely to produce an association. Neither
meta-analysis emphasized the importance of
cross-sectional associations in older children,
and both implied that the interpretation most
consistent with the overall results was that
peak blood lead concentration, achieved at
about 2 years of age, was most likely responsi-
ble for the cognitive effects, even though
these effects were not reliably detectable until
≥ 4 years of age.
These meta-analyses as well as the find-
ings from the individual prospective studies,
especially Boston (Bellinger et al. 1992), have
had a strong effect on the interpretation of
both longitudinal and cross-sectional studies.
One consequence is that if we wish to know
the minimum concentration in blood at
which lead affects cognition, then we are
obliged to follow children starting at 2 years
of age. School-age children, in whom IQ
is relatively stable and testable, have lower
blood lead concentrations. A cross-sectional
study among school-age children might
reflect latent damage done by higher blood
lead concentrations at 2 years of age but
detectable only at school age because IQ can
be more reliably tested with greater precision
at that age. This interpretation has guided
screening programs, which focus on 1- and
2-year-olds; clinical trials, which have treated
2-year-olds; and the interpretation of the
cross-sectional literature. Thus, the report in
2000 (Lanphear et al. 2000) that school-age
children studied in the third National Health
and Nutrition Examination Survey had an
inverse relationship between their concurrent
blood lead concentrations and IQ even at
blood lead concentrations < 10 µg/dL, the
current Centers for Disease Control and
Prevention (CDC) level of concern, was inter-
preted by some to reﬂect the effects of the chil-
dren’s higher blood lead concentrations when
they were 2 years old. However, after publica-
tion of prospective data showing that even
peak blood lead concentrations < 10 µg/dL in
toddlers were associated with decrements in
IQ (Canfield et al. 2003), changes in policy
were quickly considered.
It is not clear that only the peak blood
lead concentration matters. In the prospective
Boston study that examined children with
very low lead exposure, blood lead concentra-
tion at 2 years of age, but not at 57 months or
10 years of age, was significantly associated
with IQ at 10 years of age (Bellinger et al.
1992). Other prospective studies of children
with relatively high lead exposure, however,
found concurrent (Dietrich 1995; Dietrich
et al. 1993) or lifetime average blood lead
concentration (Tong et al. 1996) to be more
strongly associated with IQ measurement at
school age than were peak levels. Another
study modeling relative contribution of pre-
natal and postnatal (0–2 years, 2 to 3–7 years)
blood lead also found increases in blood lead
after 2 years of age associated with IQ deﬁcits
after 2 years of age (Wasserman et al. 2000).
Other analyses have asked whether greater
declines in blood lead concentration from the
2-year peak are associated with higher IQ later.
Two studies with analyses that adjusted for
2-year cognitive test score found that children
whose blood lead concentrations fell more
after 2 years of age had increased IQ (Liu et al.
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Increases in peak blood lead concentrations, which occur at 18–30 months of age in the United
States, are thought to result in lower IQ scores at 4–6 years of age, when IQ becomes stable and
measurable. Data from a prospective study conducted in Boston suggested that blood lead concen-
trations at 2 years of age were more predictive of cognitive deficits in older children than were
later blood lead concentrations or blood lead concentrations measured concurrently with IQ.
Therefore, cross-sectional associations between blood lead and IQ in school-age children have
been widely interpreted as the residual effects of higher blood lead concentrations at an earlier age
or the tendency of less intelligent children to ingest more leaded dust or paint chips, rather than as
a causal relationship in older children. Here we analyze data from a clinical trial in which children
were treated for elevated blood lead concentrations (20–44 µg/dL) at about 2 years of age and fol-
lowed until 7 years of age with serial IQ tests and measurements of blood lead. We found that
cross-sectional associations increased in strength as the children became older, whereas the relation
between baseline blood lead and IQ attenuated. Peak blood lead level thus does not fully account
for the observed association in older children between their lower blood lead concentrations and
IQ. The effect of concurrent blood level on IQ may therefore be greater than currently believed.
Key words: chelation, developmental testing, IQ, lead poisoning, longitudinal studies. Environ
Health Perspect 113:597–601 (2005). doi:10.1289/ehp.7625 available via http://dx.doi.org/
[Online 2 February 2005]2002; Ruff et al. 1993). However, another
study modeling change in IQ found that
decline in blood lead concentration from 2 or
4 years of age to 11–13 years of age was not
associated with IQ improvement, and that
declines in blood lead concentration from 7 to
11–13 years of age were associated with only
modestly better IQ scores (Tong et al. 1998).
Overall, the findings suggest that the longer
the blood lead is at high levels, the greater the
effect on IQ, and thus they imply that blood
lead concentration in school age may matter
because higher concentrations usually reflect
longer exposures or higher current body bur-
dens as a result of heavy exposure in earlier
years. It also raises the level of concern for chil-
dren in areas where leaded gasoline and indus-
trial sources are still a source of exposure. In
general, outdoor exposures such as these pro-
duce peak blood lead concentrations at later
ages among children (Wasserman et al. 1997).
Although such exposure may be experienced
by older and perhaps less susceptible children,
this exposure might also be more prolonged
and consequently produce more damage.
Here we examine a large prospective data
set from a clinical trial of lead poisoning treat-
ment. This data set includes blood lead con-
centrations measured frequently between entry
at about 24 months of age and the last follow-
up at 90 months, as well as the results of IQ
testing at multiple times. We sought to clarify
the strength of the association between IQ and
blood lead at the various time points, to exam-
ine whether the cross-sectional associations
seen in the 84- to 90-month-old children rep-
resent residual effects from 2 years of age or
new effects emerging among these school-age
children, and how the change in blood lead
over time is related to IQ at follow-up.
Materials and Methods
The Treatment of Lead-exposed Children
(TLC) study was a multicenter, randomized,
placebo-controlled clinical trial of 780 children
12–33 months of age with blood lead concen-
trations of 20–44 µg/dL. The study tested
whether succimer treatment of toddlers resulted
in better scores on IQ tests and other measures
of behavioral and psychological function (TLC
1998). Although succimer lowered blood lead
concentrations for about 10 months, it did not
improve test scores at 36-month (Rogan et al.
2001) or 60-month follow-up (Dietrich et al.
2004). Thus, the succimer and placebo groups
can be analyzed separately or combined to
study the effect of blood lead concentration on
cognitive test scores.
Blood lead concentration. Venous blood
was collected with lead-free containers twice
before randomization and on days 7, 28, and
42 after the beginning of each course of treat-
ment. After the termination of treatment,
blood lead concentrations were measured
every 3–4 months. From up to 24 measure-
ments of blood lead concentrations, we used
the second blood sample before randomiza-
tion at baseline (about 2 years of age), the
blood sample at 36-month follow-up (about
5 years of age), and the last blood sample at
60-month follow-up (about 7 years of age)
(TLC 2000). The peak blood lead concentra-
tion from baseline to 7 years of age was the
maximum blood lead concentration of any
of up to 24 measurements. For those having
their blood lead concentration measured at
5 or 7 years of age, average blood lead concen-
tration from baseline to 5 or 7 years of age was
calculated by dividing the area under the blood
lead concentration–age curve (inﬂecting a con-
necting line at each blood lead measurement,
and then summing the areas of the trapezoids)
by age interval. The blood lead concentrations
were measured at the Nutritional Biochemistry
Branch of the CDC by atomic absorption
spectrometry based on the methods described
by Miller et al. (1987).
Cognitive test scores. At baseline, children
were given the Bayley Scales of Infant
Development–II (BSID-II) (Bayley 1993), the
most widely used scales of infant intelligence
tests. The Mental Development Index (MDI)
of BSID-II is statistically analogous to an IQ
score. Like those from the Wechsler scales,
standard scores from the BSID-II have a mean
of 100 and standard deviation of 15. For all
these measures, raw scores are transformed into
these standard scores. The children’s full-scale
IQ at 36-month follow-up was measured
with the Wechsler Preschool and Primary
Scales of Intelligence–Revised (Wechsler
1989), and at 60-month follow-up IQ was
measured with the Wechsler Intelligence Scale
for Children–III (Wechsler 1991). At one of
the visits between enrollment and 36-month
follow-up, the caregiver’s IQ (the mother
for 88% of children, the father for 4%, and
another caregiver for 8%) was measured with
the two-subtest version of the Wechsler Adult
Intelligence Scale–Revised (Silverstein 1985;
Wechsler 1981).
Statistical analysis. We used multiple
linear regression models to analyze the
association of blood lead concentration and
cognitive scores at various ages. Both log-
transformed and untransformed blood lead
concentrations were tested in the statistical
models, and the ﬁndings were similar. In this
article, only results of untransformed blood
lead concentrations were used. Covariates
include clinical center (Baltimore, Maryland;
Cincinnati, Ohio; Newark, New Jersey; and
Philadelphia, Pennsylvania), race (black or
white/others), sex (male or female), language
(English or Spanish), parent’s education
(< 12 years, 12 years, > 12 years of educa-
tion), parent’s employment (neither working,
either working), single parent (yes or no),
age at blood lead concentration test, and
caregiver’s IQ.
First, one blood lead concentration (at 2, 5,
and 7 years of age, peak or average) was
included as an independent variable to model
IQ score (MDI at 2 years, IQ at 5 or 7 years of
age), with adjustment for covariates.
Then, to evaluate whether the cross-
sectional association was a residue of the effect
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Table 1. Blood lead concentrations and IQ scores of TLC children.
Age at tests
Variable No. Mean ± SD [years (mean ± SD)]
Blood lead concentration (µg/dL)
Baseline (2 years of age) 780 26.2 ± 5.1 2.0 ± 0.5
5 years of age 731 12.0 ± 5.2 5.0 ± 0.5
7 years of agea 622 8.0 ± 4.0 7.0 ± 0.2
Peak from baseline to 7 years of age 780 30.6 ± 6.6 2.2 ± 0.7
Average from baseline to 5 years of age 731 17.0 ± 5.0
Average from baseline to 7 years of age 622 14.4 ± 4.6
IQ score
MDI at baseline 765 82.2 ± 13.7 2.0 ± 0.5
IQ at 5 years of age 727 80.6 ± 13.3 5.0 ± 0.5
IQ at 7 years of age 644 86.7 ± 13.3 7.1 ± 0.2
aOne child with a blood lead concentration of 50.8 µg/dL was excluded from the entire analysis.
Figure 1. IQ test scores by prior or concurrent
blood lead concentration. Each data point shows
the mean IQ test scores of children measured at
baseline or at two follow-ups, grouped by quartiles
of blood lead concentration. The abscissa of each
point is the middle value of each blood lead con-
centration category.
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prior and concurrent blood lead concentration
were included in the models (blood lead con-
centration at 2 and 5 years on IQ at 5 years of
age, blood lead concentration at 2 and 7 years
on IQ at 7 years of age, blood lead concentra-
tion at 5 and 7 years on IQ at 7 years of age).
The model thus includes later IQ as the depen-
dent variable, and earlier blood lead concen-
tration, later blood lead concentration, and
covariates as the independent variables. We
also tried additional adjustment for earlier IQ,
which theoretically tests for change in IQ by
change in blood lead concentration. This
allows us to compare results with previous
studies using a similar approach (Liu et al.
2002; Ruff et al. 1993).
Quantitative analysis of both prior and
concurrent blood lead concentration in the
same model, even without adjustment for
prior IQ, still faces the problem of collinearity
between the two blood lead measurements. A
qualitative alternative may reduce the preci-
sion in estimation but should show the effect
on school-age IQ by blood lead concentration
with less distortion. Therefore, we used the
median of earlier blood lead concentration
and the median of later blood lead concentra-
tion as cutoff points to reduce earlier and later
blood lead concentrations to binary variables.
This does not eliminate the inherent correla-
tion between earlier and later blood lead con-
centrations (children with lower earlier blood
lead concentrations tend to have lower later
blood lead concentrations), but it reduces the
impact of collinearity on the stability of the
estimated regression coefﬁcients and produces
a model that is easy to interpret.
To see whether the association between
blood lead concentration and IQ score varied
by treatment group (succimer or placebo), we
repeated these regression models by treatment
group.
We used SAS (version 9.0; SAS Institute
Inc., Cary, NC) for statistical analysis. All
tests are two sided. Because of the difference
in the number of children tested for each
follow-up measurement, the sample sizes of
the different regression models vary slightly.
Results
Study subjects. Four centers were involved in
the recruitment, treatment, and follow-up of
a total of 780 children in the TLC study:
Baltimore had 213, Cincinnati had 194,
Newark had 208, and Philadelphia had 165.
Three hundred ninety-six children were ran-
domly assigned to the succimer group, and
384 to the placebo group. There were no dif-
ferences between groups in age, sex, race,
socioeconomic status, and blood lead concen-
tration of children at recruitment. The chil-
dren were mainly African American (77%),
from households speaking English (95%),
with a single parent (72%), and receiving
public assistance (97%).
Blood lead concentration and IQ scores.
The blood lead concentrations and IQ scores
of TLC children at baseline and at 5 and
7 years of age are shown in Table 1. The cor-
relation coefﬁcients of blood lead concentra-
tions at baseline and 5 or 7 years were 0.40 and
0.27, respectively; that between measurements
at 5 and 7 years was 0.78. The correlation co-
efficients of cognitive scores at baseline and
5 or 7 years were 0.54 and 0.41, respectively;
that between 5 and 7 years was 0.78. All of
these correlation coefﬁcients were statistically
significant (all p-values < 0.001). Although
mean blood lead concentration declined over
time, the standard deviations remained similar.
As shown in Table 1, the ages at IQ tests and
blood lead concentration measurements were
very close. For example, at about 7 years of age,
94% of children had IQ and blood lead tests
on the same day.
Heterogeneity between succimer and
placebo groups. There were no statistical
differences between succimer and placebo
groups in either blood lead concentrations or
cognitive scores at the time points under con-
sideration (all p-values > 0.10). The associa-
tion between blood lead concentration and
IQ score was homogeneous between treat-
ment groups except for baseline blood lead
concentration and baseline MDI: 10-µg/dL
increment at baseline had a coefﬁcient of –1.6
(SE, 1.3) MDI points in the succimer group
and –4.6 (SE, 1.4) MDI points in the placebo
group. In the regression models including
both prior and concurrent blood lead concen-
trations without additional adjustment for
prior IQ, the results were similar in the suc-
cimer and placebo groups.
Associations of blood lead concentration
and IQ. Figure 1 displays the mean IQ at cur-
rent and subsequent ages by quartiles of blood
lead measured at 2, 5, and 7 years of age.
Although blood lead concentrations decreased
over time and IQ test scores ﬁrst declined and
then increased, the inverse association between
concurrent blood lead concentration and IQ
test scores remained constant.
Table 2 shows the estimated difference
in cognitive test scores for each 10-µg/dL
change in prior, concurrent, peak, or average
blood lead concentration. Overall, the con-
current blood lead concentration always had
the strongest association with IQ, and as the
children aged, the relationship grew stronger.
The peak blood lead concentration from base-
line to 7 years of age was not associated with
IQ at 7 years of age. The average blood lead
concentration from baseline to 5 or 7 years of
age was inversely associated with IQ at 5 or
7 years of age.
Is the cross-sectional association at a later
age a residue of effects attributable to earlier
blood lead concentrations? In the model
including both prior and concurrent blood
lead concentrations, concurrent blood lead
was always more predictive of later IQ scores
(Table 3). Adjustment for prior IQ did not
significantly change the strength of associa-
tion with concurrent blood lead concentra-
tion. Alternatively, categorizing prior and
Children’s Health | IQ and blood lead from 2 to 7 years of age
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Table 2. Adjusted estimates (95% conﬁdence intervals) of the effect of a change of 10 µg/dL in ﬁve measures
of lead exposure on change on IQ test scores measured at 2, 5, and 7 years of age.
Outcome variable: Independent variable: blood lead concentration (per 10-µg/dL increment)a
IQ score (points) 2 years of age 5 years of age 7 years of age Peakb Averagec
MDI at baseline –2.9
(–4.7 to –1.0)
IQ at 5 years of age –2.3 –3.5 –2.9
(–4.1 to –0.5) (–5.3 to –1.7) (–4.8 to –1.0)
IQ at 7 years of age –1.1 –2.9 –5.4 –0.7 –3.3
(–2.9 to 0.7) (–4.8 to –1.1) (–7.8 to –2.9) (–2.1 to 0.7) (–5.4 to –1.1)
aEach combination of outcome and independent variables was modeled separately; all were adjusted for clinic center,
race, sex, language, parent’s education, parent’s employment, single parent, caregiver’s IQ, and exact age at blood lead
concentration measurement. bPeak blood lead concentration between baseline and 7 years of age. cAverage blood lead
concentration from baseline to 5 years of age for IQ at 5 years of age, and average blood lead concentration from baseline
to 7 years of age for IQ at 7 years of age.
Table 3. Adjusted estimates (95% conﬁdence intervals) of the effect of a 10-µg/dL change in prior and con-
current blood lead concentrations on IQ test scores at 5 and 7 years of age.
Additional adjustment Independent variable: blood lead concentrations
Outcome variable: for baseline MDI or (per 10-µg/dL increment)a
IQ score 5-year IQ score 2 years of age 5 years of age 7 years of age
IQ at 5 years of age None –1.2 (–3.1 to 0.7) –2.9 (–4.9 to –0.9)
Baseline MDI –0.1 (–1.8 to 1.5) –2.4 (–4.1 to –0.7)
IQ at 7 years of age None 0.1 (–1.8 to 2.0) –5.0 (–7.6 to –2.4)
Baseline MDI 0.4 (–1.4 to 2.1) –3.8 (–6.2 to –1.4)
None –1.2 (–4.1 to 1.7) –3.9 (–7.4 to 0.0)
5-year IQ 1.7 (–0.3 to 3.6) –3.7 (–6.3 to –1.1)
aEach row of results was from separate models; all were adjusted for clinic center, race, sex, language, parent’s educa-
tion, parent’s employment, single parent, caregiver’s IQ, and exact age at both blood lead measurements.concurrent blood lead concentrations by the
corresponding medians in the regression
model had similar results (Table 4). Among
children with both prior and concurrent
blood lead concentrations below the corre-
sponding medians as the reference group,
those with prior blood lead concentrations at
or above median but concurrent blood lead
concentrations below the median did not
have a decrease in school-age IQ score. In
contrast, children with concurrent blood lead
concentrations at or above the median had
roughly similar IQ decreases, irrespective of
their prior blood lead concentration.
Discussion
In these data we found a stronger relationship
between blood lead concentration at 7 years
and IQ at 7 years than between IQ at 7 years
and the higher 2-year-old blood lead concen-
tration; the association of blood lead concen-
tration at 5 years and IQ at 5 years is also
stronger than that between IQ at 5 years and
blood lead at 2 years. The strength of the cross-
sectional association increases over time (from
2 years of age to 5–7 years of age), despite
lower blood lead concentrations in older chil-
dren. This analysis supports the idea that lead
exposure continues to be toxic to children as
they reach school age, and does not support
the interpretation that all the damage is done
by the time the child is 2 or 3 years of age.
We found previously that children with
relatively greater declines in blood lead have
improved IQ, but that ﬁnding was limited to
children given placebo (Liu et al. 2002). The
analysis that yielded that result was modeled
closely on that of a previous report (Ruff et al.
1993) in which declining blood lead concen-
tration was associated with increased IQ inde-
pendent of chelation treatment, because our
primary goal was to attempt to replicate their
ﬁndings. We now suspect that the difference in
the results for placebo and succimer groups was
caused by unexpected heterogeneity in the rela-
tionship at baseline between blood lead and IQ
in the placebo and succimer groups. Removing
baseline MDI from the model that was previ-
ously used reduced the difference between
placebo and succimer groups. In neither analy-
sis did we see evidence in the overall group or
in the placebo group that blood lead at 2 years
of age determined IQ at 7 years of age.
Nevertheless, modeling two change measures
(IQ change and blood lead change) in the same
model was complicated by intraindividual
tracking in blood lead concentration and IQ
over time as well as correlation between base-
line lead and baseline IQ (Dietrich et al. 1993;
Ernhart 1993). Theoretically, putting baseline
IQ in the regression model would yield an esti-
mate of the effect of blood lead concentration
change on individual IQ change over time;
however, the baseline IQ may be on the causal
path. Also, IQ at an early age has less stability
(Sternberg et al. 2001), and the use of different
IQ test measures at 2 years of age and school
age (Liu et al. 2002; Ruff et al. 1993; Tong
et al. 1998) may actually introduce more
variance. Thus, although it is attractive to look
at change in IQ by change in blood lead when
considering the effect of an intervention, mod-
eling those changes simultaneously is complex
and can produce results that are difficult to
interpret. A simpler approach is to model IQ at
school age by prior and concurrent blood lead
concentration: If higher concurrent blood lead
concentrations are associated with lower IQ,
then it is plausible that we should attempt to
keep blood lead concentrations low.
It is prudent to ponder whether greater
association between concurrent blood lead
and IQ score at school age was due to reverse
causality. This could happen if the lower IQ
preceded higher lead concentrations. In this
data set, baseline MDI was not associated
with blood lead concentration at 7 years, with
or without adjustment of baseline blood lead.
This supports the ﬁndings of the longitudinal
Port Pirie study (Tong et al. 1996) and sup-
ports the notion that lead exposure causes
cognitive deficiency in children within
approximately normal intelligence range, but
not the reverse, although the association
between much lower IQ than seen in these
study subjects and later high blood lead
through pica cannot be tested here. Another
way in which the strengthening association
over time may be produced is to have a ﬁxed
effect of the higher blood lead concentrations
at 2 years of age concentrated in a more
restricted range of blood lead concentrations
at 7 years of age. In the TLC study, however,
the range of blood lead concentration at entry
was 24 µg/dL, and the range at 7 years of age
was 26 µg/dL, with similar standard devia-
tions. The restricted range of blood lead
concentrations in TLC at enrollment might
produce an imprecise estimate of the slope of
the relationship between IQ and blood lead
concentration, which would stabilize as the
children led different lives and their blood
lead concentrations dispersed. The slope of
blood lead concentration at 2 years of age
versus IQ at 5 years of age is similar to that
seen in the meta-analyses, and the cross-
sectional associations are similar to those seen
in studies previously reviewed (Pocock et al.
1994; Schwartz 1994). It seems unlikely that
the slope would be substantially steeper if more
children with lower values at 2 years of age
were added, because the range of 10–20 µg/dL
is the range most stably estimated from
the meta-analyses, and the TLC estimate is
already similar to it.
This finding implies that cross-sectional
associations seen in older children, such as the
school-age children in the National Health
and Nutrition Examination Survey data,
should not be dismissed as representing a
residual from early high lead exposure. Breslau
et al. (2001) recently showed that urban
Detroit, Michigan, children had declines in
IQ from 6 to 11 years of age, whereas subur-
ban children showed no change in the inher-
ently age-adjusted scores. The data suggested
that growing up in a racially segregated and
disadvantaged community might contribute
to a decline in IQ scores in the early school
years. However, urban dwelling may serve as a
surrogate of individual exposure, such as lead
exposure. TLC children had similar commu-
nities of origin as the urban children in the
study by Breslau et al. (2001). It could be that
lead exposure is causally related to this phe-
nomenon, or it could be that factors leading to
the families’ inability to improve their housing
led to both higher lead levels and lower IQ.
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Table 4. Adjusted estimates of regression coefﬁcients (95% conﬁdence intervals) of categorical blood lead
concentrations in models for IQ scores.
Outcome variable
Category of blood lead IQ at 5 yearsb IQ at 7 yearsb
concentration (µg/dL)a No. Mean score Comparison Mean score Comparison
2 years 5 years
< 24.9 < 11.4 227 83.7 Referent
< 24.9 ≥ 11.4 137 78.8 –2.9 (–5.8 to 0.1)
≥ 24.9 < 11.4 138 82.4 0.4 (–2.5 to 3.3)
≥ 24.9 ≥ 11.4 228 77.6 –4.0 (–6.6 to –1.5)
2 years 7 years
< 24.9 < 7.2 187 89.3 Referent
< 24.9 ≥ 7.2 114 84.6 –3.6 (–6.4 to –0.7)
≥ 24.9 < 7.2 121 88.9 –0.0 (–2.8 to 2.7)
≥ 24.9 ≥ 7.2 195 84.0 –3.7 (–6.2 to –1.3)
5 years 7 years
< 11.4 < 7.2 244 89.4 Referent
< 11.4 ≥ 7.2 52 85.9 –2.3 (–5.9 to 1.3)
≥ 11.4 < 7.2 62 88.2 0.3 (–3.1 to 3.7)
≥ 11.4 ≥ 7.2 255 83.9 –3.8 (–6.0 to –1.6)
aMeasured at 2 and 5 years of age, 2 and 7 years of age, and 5 and 7 years of age. bAdjusted for clinic center, race, sex,
language, parent’s education, parent’s employment, single parent, caregiver’s IQ, and exact age at both blood lead
measurements.Children’s Health | IQ and blood lead from 2 to 7 years of age
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In either case, the effect of lead exposure dur-
ing school age cannot be ruled out entirely.
We did not have a direct measure of the degree
to which the caregiver interacts with and stim-
ulates the child, such as the Home Observation
for Measurement of the Environment score
(Caldwell and Bradley 1979).
The strengths of this analysis include the
relatively large size of the data set and the
degree of testing and quality control that went
into the measurement of both blood lead and
IQ. The longitudinal nature of these data is a
requirement for this kind of analysis, and the
TLC study enjoyed remarkably high retention
rates for a longitudinal study among relatively
disadvantaged families.
Children in the TLC study had blood lead
concentrations high enough to be eligible for a
clinical trial of drug therapy. These blood lead
concentrations are considerably higher than
those of most children in the United States
today, even children in poverty (Pirkle et al.
1998). Although it may be that the relation-
ships among these variables are qualitatively
different in most children whose blood lead
levels never reach 20 µg/dL, this is unlikely
because the estimates from this study are well
within the range of reported lead effects. If
concurrent blood lead remains important
until school age for optimum cognitive devel-
opment, and if 6- and 7-year-olds are as or
more sensitive than 2-year-olds, then the dif-
ﬁculties in preventing lead exposure are mag-
niﬁed, but the potential beneﬁt of prevention
is greater.
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